Aigen Investment Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-644
Closed -$243K – 583
2026
Q1
$243K Buy
+644
New +$276K 0.06% 377
2025
Q2
– Sell
-2,194
Closed -$1.35M – 824
2025
Q1
$1.35M Buy
2,194
+192
+10% +$109K 0.22% 140
2024
Q4
$1.06M Buy
2,002
+1,502
+300% +$847K 0.19% 167
2024
Q3
$300K Buy
+500
New +$283K 0.06% 471
2024
Q1
– Sell
-687
Closed -$402K – 707
2023
Q4
$402K Buy
+687
New +$384K 0.07% 400
2021
Q4
– Sell
-644
Closed -$300K – 1054
2021
Q3
$300K Buy
+644
New +$304K 0.06% 341
2021
Q2
– Sell
-993
Closed -$457K – 507
2021
Q1
$457K Buy
+993
New +$487K 0.06% 305
2020
Q4
– Sell
-1,370
Closed -$658K – 806
2020
Q3
$658K Sell
1,370
-5,911
-81% -$2.9M 0.08% 351
2020
Q2
$3.28M Buy
7,281
+6,382
+710% +$2.85M 0.42% 33
2020
Q1
$389K Sell
899
-17
-2% -$7.59K 0.05% 516
2019
Q4
$402K Buy
+916
New +$385K 0.07% 378

Other funds holding CHE

Aigen Investment Management's CHE Position: Q2 2026 in Review

Aigen Investment Management sold out of Chemed (CHE) in Q2 2026, closing a stake of 644 shares — an estimated $243K sold.

Aigen Investment Management first reported a position in CHE in Q4 2019 and held it in 11 quarters. The position peaked at $3.28M in Q2 2020. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Aigen Investment Management reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
  • Aigen Investment Management sold 644 Chemed shares in Q2 2026, an estimated $243K.
  • Aigen Investment Management first reported a position in Chemed in Q4 2019 and held it in 11 quarters.
  • Aigen Investment Management's Chemed position peaked at $3.28M in Q2 2020.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.